The most effective drug combinations in T-ALL lines were those consisting of MK-2206/RAD-001, MK-2206/KU-63794, NVP-BAG956/KU-63794, NVP-BAG956/RAD-001, and RAD-001/KU-63794. Here, RRAD is linked to acute lymphoblastic leukemia.